Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines

Journal of Medicinal Chemistry
Dooseop KimAnn E Weber

Abstract

A series of beta-aminoamides bearing triazolopiperazines have been discovered as potent, selective, and orally active dipeptidyl peptidase IV (DPP-4) inhibitors by extensive structure-activity relationship (SAR) studies around the triazolopiperazine moiety. Among these, compound 34b with excellent in vitro potency (IC50 = 4.3 nM) against DPP-4, high selectivity over other enzymes, and good pharmacokinetic profiles exhibited pronounced in vivo efficacy in an oral glucose tolerance test (OGTT) in lean mice. On the basis of these properties, compound 34b has been profiled in detail. Further refinement of the triazolopiperazines resulted in the discovery of a series of extremely potent compounds with subnanomolar activity against DPP-4 (42b- 49b), that is, 4-fluorobenzyl-substituted compound 46b, which is notable for its superior potency (IC50 = 0.18 nM). X-ray crystal structure determination of compounds 34b and 46b in complex with DPP-4 enzyme revealed that (R)-stereochemistry at the 8-position of triazolopiperazines is strongly preferred over (S) with respect to DPP-4 inhibition.

References

Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M J ScanlanW J Rettig
Apr 1, 1993·Digestive Diseases and Sciences·A WettergrenJ J Holst
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·D MarguetN Wagtmann
Apr 3, 2001·Current Pharmaceutical Design·A S Wagman, J M Nuss
Jul 6, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A FlintA Astrup
Jan 17, 2003·The Biochemical Journal·Barbara LeitingNancy A Thornberry
Mar 12, 2004·Expert Opinion on Investigational Drugs·Torsten P Vahl, David A D'Alessio
Aug 6, 2004·Journal of Medicinal Chemistry·Lotte Bjerre Knudsen
Aug 6, 2004·Journal of Medicinal Chemistry·Ann E Weber
Aug 25, 2004·Bioorganic & Medicinal Chemistry Letters·Jinyou XuEmma R Parmee
Aug 25, 2004·Bioorganic & Medicinal Chemistry Letters·Linda L BrockunierEmma R Parmee
Aug 28, 2004·Diabetes·Carolyn F Deacon
Nov 5, 2004·Current Opinion in Pharmacology·Jens Juul Holst, Carolyn F Deacon
Mar 11, 2005·Diabetes/metabolism Research and Reviews·Juris J Meier, Michael A Nauck
Mar 12, 2005·Organic Letters·Jaume BalsellsJoseph D Armstrong
May 18, 2005·Drug Discovery Today·Loretta L Nielsen
Sep 22, 2006·Current Opinion in Pharmacology·Murielle M J Combettes
Apr 17, 2007·Bioorganic & Medicinal Chemistry Letters·Dooseop KimAnn E Weber

❮ Previous
Next ❯

Citations

Feb 4, 2012·Journal of Chemical Information and Modeling·V Lounnas, G Vriend
Sep 3, 2010·Nature Reviews. Drug Discovery·Marcin Drag, Guy S Salvesen
Jun 15, 2011·Journal of Atherosclerosis and Thrombosis·R Preston MasonTadeusz Malinski
Jun 20, 2014·Future Medicinal Chemistry·Yang Liu, Yongzhou Hu
May 21, 2020·Chemical Communications : Chem Comm·Hannah L StewartDavid R Spring
Feb 6, 2010·Organic & Biomolecular Chemistry·Gábor TasnádiFerenc Fülöp
Dec 21, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Katharina Luise HupaMichael Stephan
Apr 24, 2020·Bioorganic Chemistry·Xinxian DengFaqin Jiang
Apr 28, 2009·The Journal of Organic Chemistry·Carlos SaavedraEleuterio Alvarez
Jan 17, 2015·Chemical Reviews·Valentine G NenajdenkoAleksey V Shastin
Mar 29, 2018·Journal of Medicinal Chemistry·Ted W JohnsonMartin P Edwards
Aug 25, 2021·Bioorganic & Medicinal Chemistry·Shubham KumarAmit Mittal
Jul 23, 2015·Journal of Medicinal Chemistry·Eric P GillisNicholas A Meanwell
Feb 17, 2009·Bioorganic & Medicinal Chemistry·Shrikanth H Havale, Manojit Pal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.